Your browser is no longer supported. Please, upgrade your browser.
Settings
VAR Varian Medical Systems, Inc. daily Stock Chart
VAR [NYSE]
Varian Medical Systems, Inc.
IndexS&P 500 P/E39.82 EPS (ttm)2.76 Insider Own0.10% Shs Outstand91.90M Perf Week1.41%
Market Cap10.11B Forward P/E23.61 EPS next Y4.66 Insider Trans-64.99% Shs Float91.35M Perf Month-0.61%
Income256.40M PEG4.98 EPS next Q0.95 Inst Own- Short Float6.61% Perf Quarter4.19%
Sales2.67B P/S3.79 EPS this Y-18.70% Inst Trans-0.19% Short Ratio8.43 Perf Half Y5.91%
Book/sh16.27 P/B6.76 EPS next Y9.13% ROA7.70% Target Price105.63 Perf Year38.17%
Cash/sh7.79 P/C14.12 EPS next 5Y8.00% ROE16.90% 52W Range76.29 - 114.09 Perf YTD-1.02%
Dividend- P/FCF29.74 EPS past 5Y-6.10% ROI13.80% 52W High-2.87% Beta0.66
Dividend %- Quick Ratio1.10 Sales past 5Y-1.00% Gross Margin43.30% 52W Low45.25% ATR1.78
Employees6600 Current Ratio1.40 Sales Q/Q-1.10% Oper. Margin12.80% RSI (14)52.56 Volatility1.44% 1.40%
OptionableYes Debt/Eq0.23 EPS Q/Q-10.00% Profit Margin9.40% Rel Volume1.03 Prev Close110.02
ShortableYes LT Debt/Eq0.00 EarningsJan 24 AMC Payout0.00% Avg Volume716.07K Price110.81
Recom2.70 SMA200.13% SMA500.51% SMA2007.70% Volume737,317 Change0.72%
Jan-03-18Initiated Evercore ISI Underperform
Sep-07-17Downgrade BTIG Research Buy → Neutral
May-16-17Initiated Goldman Neutral $92
May-08-17Upgrade Citigroup Neutral → Buy
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $82 → $90
Apr-27-17Downgrade Barrington Research Outperform → Mkt Perform
Jan-27-17Reiterated Barrington Research Outperform $102 → $98
Jan-23-17Reiterated RBC Capital Mkts Sector Perform $91 → $93
Jul-28-16Reiterated Barrington Research Outperform $93 → $102
Feb-17-16Reiterated RBC Capital Mkts Sector Perform $86 → $84
Jan-12-16Resumed Barrington Research Outperform $91
Dec-22-15Initiated RBC Capital Mkts Sector Perform $86
Nov-12-15Initiated Citigroup Neutral
Oct-20-15Downgrade Robert W. Baird Outperform → Neutral $101 → $82
Sep-28-15Downgrade Goldman Neutral → Sell
Jun-18-15Initiated Dougherty & Company Buy $105
Apr-30-15Downgrade JP Morgan Overweight → Neutral
Jan-29-15Reiterated Brean Capital Buy $87 → $96
Oct-23-14Reiterated ISI Group Neutral $86 → $82.50
Oct-23-14Reiterated Brean Capital Buy $95 → $85
Jan-23-18 02:10PM  Intuitive Surgicals Da Vinci Procedure Could Boost 2017 Results Market Realist
08:25AM  Recent Analysis Shows Varian Medical, Deckers Outdoor, Copart, Systemax, TPG Specialty Lending, and Cohen & Steers Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jan-22-18 10:34AM  What's in the Cards for Varian Medical (VAR) in Q1 Earnings? Zacks
Jan-19-18 05:50PM  Varian Medical Systems: Earnings Expected to Rise 26.8% in 1Q18 Market Realist
04:20PM  Will Varian Medical Systems Sales Decline Again in 1Q18? Market Realist
02:50PM  Analyst Recommendations for Varian Medical Systems before 1Q18 Market Realist
Jan-15-18 04:13AM  New Strong Sell Stocks for January 15th Zacks
Jan-09-18 08:26AM  New Strong Sell Stocks for January 9th Zacks
Jan-08-18 08:15AM  Varian and Ping An Sign Memorandum of Understanding to Expand Access to High Quality Cancer Care in China PR Newswire
08:10AM  Varian Halcyon Treatment System Receives Taiwan FDA Approval PR Newswire
Jan-03-18 04:09PM  Varian to Discuss New Reporting Standards PR Newswire
Jan-01-18 09:13AM  Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q4, 2017 By the Numbers : January 1, 2018 Capital Cube
Dec-28-17 04:09PM  Varian Publishes 2017 Annual Report PR Newswire
07:32AM  How Has Varian Medical Systems Stock Been Performing Recently? Market Realist
Dec-27-17 01:00PM  How Varian Has Expanded Its Global Footprint Market Realist
11:30AM  Eclipse System Expands Varians Market Presence in Australia Market Realist
09:59AM  Discussing Analysts Latest Recommendations on VAR Stock Market Realist
Dec-18-17 11:15PM  Varian Medical Systems Inc (VAR) President and CEO Dow R Wilson Sold $9.9 million of Shares GuruFocus.com
04:05PM  Varian to Present at 36th Annual J.P. Morgan Healthcare Conference PR Newswire
08:22AM  Varian Gains Ground on New Applications, Grows in Australia Zacks
Dec-12-17 05:00PM  Peter MacCallum Cancer Centre Standardizes on Varian Solution for Cancer Treatment Planning PR Newswire
Dec-11-17 04:09PM  Varian Announces First Quarter Fiscal Year 2018 Earnings Release Date PR Newswire
Dec-08-17 08:31AM  Varian Halcyon Gets ANVISA Registration, Grows in Oncology Zacks
Dec-06-17 08:15AM  Varian Halcyon Treatment System Receives ANVISA Registration in Brazil PR Newswire
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Dec-05-17 09:01AM  Varians Latest Wall Street Recommendations: Mostly Hold Market Realist
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
07:31AM  Varians Long-Term Growth Strategy: Will It Drive 2018 Guidance? Market Realist
Dec-04-17 10:32AM  A Look at Varian Medical Systems Long-Term Objectives Market Realist
09:02AM  Varian Medical Systems Profitability Profile Market Realist
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
07:33AM  Varians Performance by Geography and Future Growth Potential Market Realist
01:20AM  Varian Partners with Penn Medicine for Proton Therapy Training and Education Program PR Newswire
Dec-01-17 11:40AM  Varians Halcyon System Sees Strong Global Growth Momentum Market Realist
10:10AM  How Double-Digit Orders Growth Is Driving Varian Medical Systems Market Realist
08:38AM  Varian Stock Rallied to 52-Week High on November 29 Market Realist
08:05AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Nov-30-17 08:43AM  Varian's Partners Penn Medicine, Proton Therapy in Focus Zacks
Nov-28-17 04:05PM  Varian Medical Systems Schedules Annual Stockholder Meeting In Palo Alto PR Newswire
08:16AM  Is Varian Medical Systems Incs (VAR) Liquidity As Good As Its Solvency? Simply Wall St.
08:15AM  Varian Partners with Penn Medicine for Proton Therapy Training and Education Program PR Newswire
08:00AM  Varian Medical Systems To Present At The Citi 2017 Global Healthcare Conference PR Newswire
Nov-27-17 06:48PM  Varian Medical Systems Inc (VAR) Files 10-K for the Fiscal Year Ended on September 30, 2017 GuruFocus.com
08:06AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Nov-22-17 09:09AM  Varian to Open Facility in Brazil, Global Growth in Focus Zacks
Nov-20-17 06:39PM  Varian Announces Opening of New Facility in Brazil PR Newswire
09:50AM  Varian's Halcyon Receives Shonin Approval, Grows in Oncology Zacks
Nov-16-17 08:15AM  Varian Halcyon Treatment System Receives Shonin Approval PR Newswire
07:30AM  Earnings Review and Free Research Report: Varians Adjusted EPS Increased 5.8% ACCESSWIRE
02:00AM  DNAmito Inc. to Integrate Genomics-Based Personalized Analysis With Varian's Oncology Care Management Software Platform to Optimize Physician's Decisions Regarding Radiation Treatment for Cancer PR Newswire
Nov-14-17 08:15AM  Varian to Showcase Technologies for Enhancing Oncology Care Coordination at AONN+ Conference PR Newswire
08:06AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Nov-06-17 08:00AM  Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems PR Newswire
03:00AM  Varian Medical Systems Earns Relative Strength Rating Upgrade; Hits Key Benchmark Investor's Business Daily
Nov-03-17 08:00AM  Varian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagen's Rigshospitalet and Herlev Hospital PR Newswire
Nov-01-17 08:15AM  Global Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in Australia PR Newswire
Oct-31-17 08:33AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : October 31, 2017 Capital Cube
Oct-30-17 08:15AM  Varian Names New Chief People Officer, SVP HR PR Newswire
Oct-27-17 08:11AM  Edited Transcript of VAR earnings conference call or presentation 25-Oct-17 9:00pm GMT Thomson Reuters StreetEvents
Oct-25-17 06:48PM  Varian Medical tumbles more than 6% after disappointing earnings, forecast MarketWatch
04:20PM  Varian Selected to Provide Proton System and Software for Oncology Hospital in South China PR Newswire
04:15PM  Varian Compact Single-room Proton Therapy System Selected by Penn Medicine for New Treatment Center PR Newswire
04:02PM  Varian Reports Results for Fourth Quarter of Fiscal Year 2017 PR Newswire
Oct-24-17 12:30PM  MedTech Stocks (BAX, VAR, TMO, LH) Earnings Preview: What You Should Know Zacks
08:15AM  First Patients in US Treated with Varian HyperArc High Definition Radiotherapy PR Newswire
Oct-23-17 08:00AM  Eye Cancer Patient Treated Using Varian's new HyperArc High Definition Radiotherapy Technology PR Newswire
Oct-20-17 10:11AM  Mass confusion over Obamacare plans Yahoo Finance Video
06:41AM  Varian Medical (VAR) Q4 Earnings: Is a Surprise in Store? Zacks
Oct-19-17 09:38AM  Varian Medical (VAR) Initiates Halcyon Treatment in Europe Zacks
Oct-17-17 08:15AM  UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System PR Newswire
Oct-11-17 12:34PM  Varian Medical Systems, Inc. Value Analysis (NYSE:VAR) : October 11, 2017 Capital Cube
Oct-10-17 08:26AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : October 10, 2017 Capital Cube
Oct-09-17 08:06AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Oct-02-17 08:15AM  Varian Publishes 2017 Sustainability Report PR Newswire
Sep-29-17 10:05AM  Varian Medical Initiates Treatment Using Halcyon System Zacks
Sep-28-17 08:30AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : September 28, 2017 Capital Cube
Sep-25-17 07:42AM  How Varian Medical Systems Is Advancing Cancer Care Market Realist
06:26AM  Varians Halcyon Reaches Milestone Achievements Market Realist
06:26AM  Why Most Analysts Recommend a Buy for Varian Medical Systems Market Realist
06:26AM  Key Growth Driver: Varian Medical Systems Launched Eclipse 15.5 Market Realist
Sep-21-17 08:45AM  Varian Announces Penn Medicine Treats World's First Patient on Halcyon System PR Newswire
Sep-20-17 08:15AM  Varian Ranks First in Overall Manufacturer, System, and Service Performance in 2017 Survey of Radiation Oncology Professionals PR Newswire
Sep-19-17 08:58AM  Varian Medical (VAR) Releases FDA-Approved Eclipse 15.5 Zacks
08:15AM  Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017 PR Newswire
Sep-18-17 08:15AM  Varian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5 PR Newswire
08:06AM  Varian Conducts Clinical Workshop, Strengthens Algeria Hold Zacks
Sep-14-17 08:04AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
08:00AM  Varian Holds First Clinical Workshop at New Algeria Facility PR Newswire
Sep-13-17 08:04AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Sep-12-17 08:04AM  See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Markit
Aug-24-17 08:00AM  Varian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor Events PR Newswire
Aug-23-17 09:00AM  Varian Medical Systems, Inc. breached its 50 day moving average in a Bullish Manner : VAR-US : August 23, 2017 Capital Cube
Aug-21-17 05:24PM  ETFs with exposure to Varian Medical Systems, Inc. : August 21, 2017 Capital Cube
Aug-16-17 10:36AM  Varian Medical Systems Recent Stock Performance Market Realist
09:07AM  What Drove Varian to Revise Its Revenue Guidance Market Realist
08:22AM  Varian (VAR) Rides on Oncology and Proton Therapy Businesses Zacks
07:36AM  How Varian Is Harnessing Proton Therapy Market Opportunities Market Realist
Aug-15-17 10:36AM  Varians Halcyon Treatment System Sees Emerging Market Demand Market Realist
09:05AM  Varians Oncology Business Grows in Emerging Markets Market Realist
07:37AM  Why Varian Medical Systems Profitability Is Improving Market Realist
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Varian Particle Therapy segment develops, designs, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 16Option Exercise81.9793376,47827,595Jan 17 06:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 16Option Exercise67.1286357,92528,224Jan 17 07:05 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 16Sale108.4386393,57527,361Jan 17 07:05 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 16Sale108.31933101,05626,662Jan 17 06:58 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 12Option Exercise67.121,08973,09427,751Jan 16 05:04 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jan 12Sale108.191,089117,82326,662Jan 16 05:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 08Option Exercise73.957,991590,94435,352Jan 10 03:05 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJan 08Sale110.657,991884,20027,361Jan 10 03:05 PM
GUERTIN TIMOTHY EDirectorJan 02Sale111.4610,0001,114,64165,800Jan 03 06:19 PM
WILSON DOW RPresident and CEODec 18Option Exercise60.9188,7665,406,737155,542Dec 18 09:24 PM
WILSON DOW RPresident and CEODec 18Sale111.0088,7669,852,93566,776Dec 18 09:24 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 13Option Exercise81.9793176,31427,593Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 13Sale113.01931105,21026,662Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 12Option Exercise67.121,08772,95927,749Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Dec 12Sale111.091,087120,75426,662Dec 13 08:41 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Nov 13Option Exercise73.982,021149,50527,750Nov 14 06:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Nov 13Sale107.362,021216,98326,662Nov 14 06:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 18Option Exercise81.9793176,31427,531Oct 19 08:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 18Sale105.0093197,75526,600Oct 19 08:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 12Option Exercise67.121,08873,02727,688Oct 13 03:23 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Oct 12Sale101.551,088110,48926,600Oct 13 03:23 PM
WILSON DOW RPresident and CEOOct 06Option Exercise51.2315,059771,47381,835Oct 06 07:46 PM
ECKERT R ANDREWDirectorOct 06Option Exercise62.745,651354,54414,650Oct 06 07:55 PM
ECKERT R ANDREWDirectorOct 06Sale102.395,651578,5948,999Oct 06 07:55 PM
WILSON DOW RPresident and CEOOct 06Sale102.4015,0591,541,97866,776Oct 06 07:46 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 13Option Exercise0.00933027,533Sep 14 11:36 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 13Sale107.29933100,10026,600Sep 14 11:36 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 12Option Exercise0.001,088027,688Sep 13 11:25 AM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Sep 12Sale107.331,088116,77826,600Sep 13 11:25 AM
WILSON DOW RPresident and CEOSep 07Option Exercise0.0015,059081,835Sep 08 03:05 PM
WILSON DOW RPresident and CEOSep 07Sale105.4115,0591,587,36766,776Sep 08 03:05 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 31Option Exercise81.9793176,31427,531Sep 01 03:48 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 31Sale105.0093197,75526,600Sep 01 03:48 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 14Option Exercise67.121,08873,02726,600Aug 15 07:56 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Aug 14Sale97.911,088106,52526,600Aug 15 07:56 PM
WILSON DOW RPresident and CEOAug 07Option Exercise51.2315,059771,47381,835Aug 08 08:08 PM
WILSON DOW RPresident and CEOAug 07Sale96.4815,0591,452,89566,776Aug 08 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 13Option Exercise81.9793376,47827,533Jul 13 07:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 13Option Exercise81.9773460,16627,361Jul 13 08:08 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 13Sale104.3873476,61427,261Jul 13 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 13Sale105.0093397,96526,600Jul 13 07:59 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 12Option Exercise67.121,08873,02727,688Jul 13 07:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 12Option Exercise67.1286357,92528,224Jul 13 08:08 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 12Sale104.4886390,16627,361Jul 13 08:08 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jul 12Sale104.491,088113,69026,600Jul 13 07:59 PM
WILSON DOW RPresident and CEOJul 10Option Exercise51.2315,060771,52481,836Jul 11 07:26 PM
WILSON DOW RPresident and CEOJul 10Sale103.3715,0601,556,70166,776Jul 11 07:26 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 20Option Exercise81.9726,0922,138,76152,692Jun 21 04:49 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 20Sale105.0026,0922,739,66026,600Jun 21 04:49 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 13Option Exercise81.9773460,16628,095Jun 14 07:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 13Sale101.9173474,80027,361Jun 14 07:07 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 12Option Exercise67.121,08772,95927,687Jun 13 07:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 12Option Exercise67.1286357,92528,224Jun 13 07:11 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 12Sale101.2586387,37827,361Jun 13 07:11 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 12Sale101.201,087110,00026,600Jun 13 07:07 PM
GUERTIN TIMOTHY EDirectorJun 09Sale103.2216,0001,651,54675,800Jun 12 07:48 PM
LARET MARK RDirectorJun 08Sale103.471,428147,7612,161Jun 09 04:02 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 01Option Exercise70.6356,5733,995,84883,173Jun 02 06:59 PM
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys.Jun 01Sale99.7656,5735,643,90026,600Jun 02 06:59 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 31Option Exercise81.9719,8191,624,56347,180Jun 01 03:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 31Sale99.6719,8191,975,36027,361Jun 01 03:58 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Option Exercise67.1286257,85728,223May 12 06:48 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Sale96.3986283,08427,361May 12 06:48 PM
BOSTROM SUSAN LDirectorMay 02Sale91.083,589326,9023,809May 03 06:29 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 12Option Exercise67.1286457,99227,914Apr 13 07:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 12Sale89.7486477,53327,050Apr 13 07:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 17Option Exercise74.063,876287,05730,926Mar 20 07:38 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 17Sale91.753,876355,62327,050Mar 20 07:38 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 13Option Exercise67.1286257,85727,912Mar 14 08:34 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 13Sale87.8986275,75827,050Mar 14 08:34 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 01Option Exercise67.1210,353694,89337,403Mar 02 08:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 01Sale84.8110,353878,03827,050Mar 02 08:04 PM
LARET MARK RDirectorFeb 22Option Exercise60.0111,302678,17714,891Feb 24 05:10 PM
LARET MARK RDirectorFeb 22Sale83.5611,302944,4083,589Feb 24 05:10 PM
DUGAN REGINA EDirectorFeb 21Option Exercise0.002,16102,161Feb 22 05:20 PM
ILLINGWORTH DAVID JDirectorFeb 21Option Exercise0.002,16105,134Feb 22 05:17 PM
LARET MARK RDirectorFeb 21Option Exercise0.002,16103,589Feb 22 05:15 PM
GUERTIN TIMOTHY EDirectorFeb 21Option Exercise0.002,16102,161Feb 22 05:12 PM
ECKERT R ANDREWDirectorFeb 21Option Exercise0.002,16109,304Feb 22 05:08 PM
BOSTROM SUSAN LDirectorFeb 21Option Exercise0.002,16107,398Feb 22 05:02 PM